Atlas company financials

WEST PHARMACEUTICAL SERVICES INC

Standardized 18-year financial series for WEST PHARMACEUTICAL SERVICES INC, built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0000105770FY2008 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$3.1B

Adjusted EBITDA

—

Net result

$493.7M

Net financial debt

-$588.5M

Latest source: FY2025 filing · published data snapshot generated April 26, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$844.9M

TTM revenue

$3.1B

TTM free cash flow

—

Latest quarter net result

$138.8M

Quarterly coverage: 51 periods · latest quarter FY2026-Q1 · TTM revenue growth 7.7%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
comparative · west-pharmaceutical-services-inc-fy2008 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2011-02-28 · Retrieved: 2026-04-26T11:44:04.365187+00:00
SEC EDGAR companyfacts
primary · west-pharmaceutical-services-inc-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2012-03-01 · Retrieved: 2026-04-26T11:44:04.365187+00:00
SEC EDGAR companyfacts
primary · west-pharmaceutical-services-inc-fy2012 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2013-02-27 · Retrieved: 2026-04-26T11:44:04.365187+00:00
SEC EDGAR companyfacts
primary · west-pharmaceutical-services-inc-fy2013 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2014-02-27 · Retrieved: 2026-04-26T11:44:04.365187+00:00
SEC EDGAR companyfacts
primary · west-pharmaceutical-services-inc-fy2014 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2015-02-25 · Retrieved: 2026-04-26T11:44:04.365187+00:00

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2008	1B	—	124M	86M	135M	-139M	—	comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda · missing current assets · missing current liabilities · missing inventory · missing net financial debt · missing total assets
FY2009	1B	—	98M	73M	138M	-105M	296M	comparative annual fact carried from later 10k · missing adjusted ebitda
FY2010	1B	—	91M	65M	138M	-71M	248M	missing adjusted ebitda
FY2011	1B	—	110M	—	131M	-95M	208M	missing adjusted ebitda · missing net result
FY2012	1B	—	135M	—	187M	-131M	217M	missing adjusted ebitda · missing net result
FY2013	1B	—	162M	—	221M	-152M	141M	missing adjusted ebitda · missing net result
FY2014	1B	—	182M	—	183M	-112M	54M	missing adjusted ebitda · missing net result
FY2015	1B	—	129M	—	212M	-132M	-46M	missing adjusted ebitda · missing net result
FY2016	2B	—	197M	—	219M	-170M	23M	missing adjusted ebitda · missing net result
FY2017	2B

Filing provenance